Clinical Trial Center Maastricht   Report issue

For profit
Founded: Maastricht Netherlands (2004)

Organization Overview

First Clinical Trial
2016
NCT02521220
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

citrulline (1 trial)

imiquimod (aldara) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2